ABSTRACT
Purpose
Ultrasound can be used to release a therapeutic payload encapsulated within a perfluorocarbon (PFC) emulsion via acoustic droplet vaporization (ADV), a process whereby the PFC phase is vaporized and the agent is released. ADV-generated microbubbles have been previously used to selectively occlude blood vessels in vivo. The coupling of ADV-generated drug delivery and occlusion has therapeutically synergistic potentials.
Methods
Micron-sized, water-in-PFC-in-water (W1/PFC/W2) emulsions were prepared in a two-step process using perfluoropentane (PFP) or perfluorohexane (PFH) as the PFC phase. Fluorescein or thrombin was contained in the W1 phase.
Results
Double emulsions containing fluorescein in the W1 phase displayed a 5.7±1.4-fold and 8.2±1.3-fold increase in fluorescein mass flux, as measured using a Franz diffusion cell, after ADV for the PFP and PFH emulsions, respectively. Thrombin was stably retained in four out of five double emulsions. For three out of five formulations tested, the clotting time of whole blood decreased, in a statistically significant manner (p < 0.01), when incubated with thrombin-loaded emulsions exposed to ultrasound compared to emulsions not exposed to ultrasound.
Conclusions
ADV can be used to spatially and temporally control the delivery of water-soluble compounds formulated in PFC double emulsions. Thrombin release could extend the duration of ADV-generated, microbubble occlusions.
Similar content being viewed by others
Abbreviations
- ACT:
-
activated clotting time
- ADV:
-
acoustic droplet vaporization
- CPD:
-
citrate-phosphate-dextrose
- IU:
-
international units
- PEG:
-
polyethylene glycol
- PFC:
-
perfluorocarbon
- PFH:
-
perfluoro-n-hexane
- PFP:
-
perfluoro-n-pentane
- PRP:
-
pulse repetition period
- US:
-
ultrasound
- W1/PFC/W2 :
-
water-in-perfluorocarbon-in-water
REFERENCES
Dayton PA, Zhao S, Bloch SH, Schumann P, Penrose K, Matsunaga TO, et al. Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy. Mol Imaging. 2006;5(3):160–74.
Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 2008;126(3):187–204.
Laing ST, Kim H, Kopechek JA, Parikh D, Huang S, Klegerman ME, et al. Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo. J Liposome Res. 2010;20(2):160–7.
Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci. 2007;32(8):962–90.
Unger EC, Porter T, Culp W, LaBell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev. 2004;56(9):1291–314.
Eisenbrey JR, Burnstein OM, Kambhamptai R, Forsberg F, Liu J, Wheatley M. Development and optimization of doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery. J Control Release. 2010;143(1):38–44.
Lentacker I, Geers B, Demeester J, Smedt SCD, Sanders NN. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubucin delivery: cytotoxicity and mechanisms involved. Mol Ther. 2010;18(1):101–8.
Liang H, Tang J, Halliwell M. Sonoporation, drug delivery, and gene therapy. Proc Inst Mech Eng H. 2010;224(H2):343–61.
Ren JL, Xu CS, Zhou ZY, Zhang Y, Li XS, Zheng YY, et al. A novel ultrasound microbubble carrying gene and tat peptide: preparation and characterization. Acad Radiol. 2009;16(12):1457–65.
Datta S, Coussios CC, Ammi AY, Mast TD, de Courten-Myers GM, Holland CK. Ultrasound-enhanced thrombolysis using Definity as a cavitation nucleation agent. Ultrasound Med Biol. 2008;34(9):1421–33.
Yang FY, Liu SH, Ho FM, Chang CH. Effect of ultrasound contrast agent dose on the disruption of focused-ultrasound-induced blood-brain barrier disruption. J Acoust Soc Am. 2009;126(6):3344–9.
Dayton PA, Ferrara KW. Targeted imaging using ultrasound. J Magn Reson Imaging. 2002;16(4):362–77.
Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev. 2008;60(10):1153–66.
Tinkov S, Bekeredjian R, Winter G, Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci. 2009;98(6):1935–61.
Diaz-Lopez R, Tsapis N, Fattal E. Liquid perfluorocarbons as contrast agents for ultrasonography and 19F-MRI. Pharm Res. 2010;27(1):1–16.
Riess JG. Oxygen carriers (“blood substitutes”)—raison d’etre, chemistry, and some physiology. Chem Rev. 2001;101(9):2797–919.
Fabiilli ML, Haworth KJ, Sebastian IE, Kripfgans OD, Carson PL, Fowlkes JB. Delivery of chlorambucil using acoustically-triggered, perfluoropentane emulsions. Ultrasound Med Biol. 2010;36(8):1364–75.
Fang JY, Hung CF, Liao MH, Chien CC. A study of the formulation design of acoustically active lipospheres as carriers for drug delivery. Eur J Pharm Biopharm. 2007;67(1):67–75.
Fang JY, Hung CF, Hua SC, Hwang TL. Acoustically active pefluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytoxicity against cancer cells. Ultrasonics. 2009;49(1):39–46.
Hwang TL, Lin YJ, Chi CH, Huang TH, Fang JY. Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery. J Pharm Sci. 2009;98(10):3735–47.
Apfel RE. Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis. Patent 5,840,276, Apfel Enterprises, Inc., November 1998.
Giesecke T, Hynynen K. Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. Ultrasound Med Biol. 2003;29(9):1359–65.
Kripfgans OD, Fowlkes JB, Miller DL, Eldevik OP, Carson PL. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol. 2000;26(7):1177–89.
Kawabata K, Sugita N, Yoshikawa H, Azuma T, Umemura S. Nanoparticles with multiple perfluorocarbons for controllable ultrasonically induced phase shifting. Jpn J Appl Phys. 2005;44(6B):4548–52.
Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam KH. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release. 2009;138(2):268–76.
Kripfgans OD, Fowlkes JB, Woydt M, Eldevik OP, Carson PL. In vivo droplet vaporization for occlusion therapy and phase aberration correction. IEEE Trans Ultrason Ferroelectr Freq Control. 2002;49(2):726–38.
Kripfgans OD, Orifici CM, Carson PL, Ives KA, Eldevik OP, Fowlkes JB. Acoustic droplet vaporization for temporal and spatial control of tissue occlusion: A kidney study. IEEE Trans Ultrason Ferroelectr Freq Control. 2005;52(7):1101–10.
Zhang M, Fabiilli ML, Haworth KJ, Fowlkes JB, Kripfgans OD, Roberts W, et al. Initial investigation of acoustic droplet vaporization for occlusion in canine kidney. Ultrasound Med Biol. 2010;36(10):1691–703.
Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K, Sugimura Y. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Int J Urol. 2007;14(7):585–90.
Wu F, Wang Z, Chen W, Zou J, Bai J, Zhu H, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005;235(2):659–67.
Charbonnet P, Toman J, Buhler L, Vermeulen B, Morel P, Becker C, et al. Treatment of gastrointestinal hemorrhage. Abdom Imaging. 2005;30(6):719–26.
Petroianu A. Arterial embolization for hemorrhage caused by hepatic arterial injury. Dig Dis Sci. 2007;52(10):2478–81.
Debrun G, Aletich V, Ausman J, Charbel F, Dujovny M. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery. 1997;40(1):112–20.
Taki W, Yonekawa Y, Iwata H, Uno A, Yamashita K, Amemiya H. A new liquid material for embolization of arteriovenous-malformations. AMJR Am J Neuroradiol. 1990;11(1):163–8.
Yamashita K, Taki W, Iwata H, Kikuchi H. A cationic polymer, Eudragit-E as a new liquid embolic material for arteriovenous malformations. Neuroradiology. 1996;38 Suppl 1:S151–6.
Krueger K, Zaehringer M, Strohe D, Struetzer H, Boecker J, Lackner K. Postcatheterization pseudoaneurysm: results of US-guided percutaneous thrombin injection in 240 patients. Radiology. 2005;236(3):1104–10.
Paulson EK, Sheafor DH, Kliewer MA, Nelson RC, Eisenberg LB, Sebastian MW, et al. Treatment of iatrogenic femoral arterial pseudoaneurysms: comparison of US-guided thrombin injection with compression repair. Radiology. 2000;215(2):403–8.
Holtze C, Rowat AC, Aggresti JJ, Hutchinson JB, Angile FE, Schmitz CHJ, et al. Biocompatible surfactants for water-in-fluorocarbon emulsions. Lab Chip. 2008;8(10):1632–9.
Tonelli C, Di Meo A, Fontana S, Russo A. Perfluoropolyether functional oligomers: unusual reactivity in organic chemistry. J Fluor Chem. 2002;118(1–2):107–21.
Zhu S, Edmonds WF, Hillmyer MA, Lodge TP. Synthesis and self-assembly of highly incompatible polybutadiene-poly(hexafluoropropylene oxide) diblock copolymers. J Polym Sci B Polym Phys. 2005;43(24):3685–94.
Benichou A, Aserin A. Recent developments in O/W/O multiple emulsions. In: Aserin A, editor. Multiple emulsions: technology and applications. Hoboken: Wiley-Interscience; 2008. p. 165–207.
Fabiilli ML, Haworth KJ, Fakhri NH, Kripfgans OD, Carson PL, Fowlkes JB. The role of inertial cavitation in acoustic droplet vaporization. IEEE Trans Ultrason Ferroelectr Freq Control. 2009;56(5):1006–17.
Kripfgans OD, Fabiilli ML, Carson PL, Fowlkes JB. On the acoustic vaporization of micrometer-sized droplets. J Acoust Soc Am. 2004;116(1):272–81.
Gibson J, Rees S, McManus T, Scheitlin W. A citrate-phosphate-dextrose solution for the preservation of human blood. Am J Clin Pathol. 1957;28(6):569–78.
Edwards C, Heptinstall S, Lowe K. Pluronic F-68 inhibits agonist-induced platelet aggregation in whole human blood in vitro. Artif Cells Blood Substit Immobil Biotechnol. 1998;26(5):441–7.
Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol. 2000;18(10):412–20.
Florence AT, Whitehill D. The formulation and stability of multiple emulsions. Int J Pharm. 1982;11(4):277–308.
Matsumoto S, Kita Y, Yonezawa D. An attempt at preparing water-in-oil-in-water multiple-phase emulsions. J Colloid Interface Sci. 1976;57(2):353–61.
Zhang X, Liu X, Gu D, Zhou W, Xie T, Mo Y. Rheological models for xanthan gum. J Food Eng. 1996;27(2):203–9.
Putney SD. Encapsulation of proteins for improved delivery. Curr Opin Chem Biol. 1998;2(4):548–52.
Le Borgne SL, Graber M. Amidase activity and thermal stability of human thrombin. Appl Biochem Biotechnol. 1994;48(2):125–35.
Papadopoulou MV, Ji M, Bloomer WD. NLCQ-1, a novel hypoxic cyototoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivo. Int J Radiat Oncol Biol Phys. 1998;42(4):775–9.
Courrier HM, Vandamme TF, Krafft MP. Reverse water-in-fluorocarbon emulsions and microemulsions obtained with a fluorinated surfactant. Colloids Surf A Physiochem Eng Asp. 2004;244(1–3):141–8.
Jeon S, Lee J, Andrade J, de Gennes P. Protein-surface interactions in the presence of polyethylene oxide. J Colloid Interface Sci. 1991;142(1):149–58.
Roach LS, Song H, Ismagilov RF. Controlling nonspecific protein adsorption in a plug-based microfluidic system by controlling interfacial chemistry using fluorous-phase surfactants. Anal Chem. 2005;77(3):785–96.
Clausell-Tormos J, Lieber D, Baret JC, El-Harrak A, Miller OJ, Frenz L, et al. Droplet- based microfluidic platforms for the encapsulation and screening of mammalian cells and multicellular organisms. Chem Biol. 2008;51(42):427–37.
Jumaa M, Muller BW. The effect of oil components and homogenization conditions on the physiochemical properties and stability of parenteral fat emulsions. Int J Pharm. 1998;163(1):81–9.
Lundblad RL, Bradshaw RA, Gabriel D, Ortel TL, Lawson J, Mann KG. A review of the therapeutic uses of thrombin. Thromb Haemost. 2004;91(5):851–60.
Jesty S. The kinetics of inhibition of α-thrombin in human plasma. J Biol Chem. 1986;261(22):10313–8.
Chandy T, Das GS, Wilson RF, Rao GH. Development of polylactide microspheres for protein encapsulation and delivery. J Appl Polym Sci Symp. 2002;86(5):1285–95.
Ziv O, Lublin-Tennenbaum T, Margel S. Synthesis and characterization of thrombin conjugated γ-Fe2O3 magnetic nanoparticles for hemostasis. Adv Eng Mat. 2009;11(12):B251–60.
Ziv-Polat O, Topaz M, Brosh T, Margel S. Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials. 2010;31(4):741–7.
Marchioni C, Riccardi E, Spinelli S, dell’Unto F, Grimaldi P, Bedini A, et al. Structural changes induced in proteins by therapeutic ultrasounds. Ultrasonics. 2009;49(6–7):569–76.
Oliva A, Santovena A, Farina J, Llabres M. Effect of high shear rate on stability of proteins: kinetic study. J Pharm Biomed Anal. 2003;33(2):145–55.
Jiao J, Burgess DJ. Multiple emulsion stability: pressure balance and interfacial film strength. In: Aserin A, editor. Multiple emulsions: technology and applications. Hoboken: Wiley-Interscience; 2008. p. 1–28.
Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev. 2007;21(3):131–42.
Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70(1):165–72.
Higashi S, Tabata N, Kono K, Maeda Y, Shimizu M, Nakashima T, et al. Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma. J Pharmacol Exp Ther. 1999;289(2):816–9.
Taghizadeh M, Asadpour T. Effect of molecular weight on the ultrasonic degradation of poly(vinyl-pyrrolidone). Ultrason Sonochem. 2009;16(2):280–6.
ACKNOWLEDGMENTS
The authors would like to thank Dr. Xia Shao (Department of Nuclear Medicine, University of Michigan, Ann Arbor, MI) for assistance with the Krytox-PEG copolymer synthesis and Dr. Kim Ives (Department of Radiology, University of Michigan, Ann Arbor, MI) for assistance in acquiring blood. The authors would also like to thank Dr. Olivier Couture (Ondes et Images, Institut Langevin, Paris, France) for useful discussions regarding reverse PFC emulsions. This work was supported in part by NIH grant 5R01EB000281.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fabiilli, M.L., Lee, J.A., Kripfgans, O.D. et al. Delivery of Water-Soluble Drugs Using Acoustically Triggered Perfluorocarbon Double Emulsions. Pharm Res 27, 2753–2765 (2010). https://doi.org/10.1007/s11095-010-0277-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-010-0277-5